Evaluation of Endobronchial Ultrasound (EBUS) for Staging Lung Cancer

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01799980

Acronym

EBUS

Enrollment

Registered

2013-02-27

Start date

2012-06-30

Completion date

2018-12-31

Last updated

2019-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Keywords

Lung cancer, Cervical mediastinoscopy, Endobronchial ultrasound, Staging

Brief summary

This study will compare two different methods of staging lung cancer to determine whether endobronchial ultrasound (EBUS) staging of mediastinal lymph nodes will provide good diagnostic yield in detecting lung cancer, when compared to current methods of a staging bronchoscopy and cervical mediastinoscopy.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Patients, \> 18 years of age, Gender- Males and Female Diagnosis of Non Small Cell Lung Cancer. Patients who have consented on an Ottawa Hospital consent form to undergo a mediastinoscopy procedure or EBUS-TBNA, and a Positron emission tomography (PET) of the chest for lung cancer staging.

Exclusion criteria

Females who are pregnant (or found to be pregnant) during the course of this research study. Patients who do not provide their Ottawa Hospital consent to undergo a staging bronchoscopy , cervical mediastinoscopy or EBUS-TBNA.

Design outcomes

Primary

Measure	Time frame	Description
Lung cancer staging	Pre-op and post-op	Lung cancer staging (assessed by either cervical mediastinoscopy or EBUS) will be compared both pre-op and post-op.

Countries

Canada

Outcome results